BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16113711)

  • 1. Australian women's experience with Implanon.
    Weisberg E; Fraser I
    Aust Fam Physician; 2005 Aug; 34(8):694-6. PubMed ID: 16113711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etonogestrel implant as a contraceptive choice; patient acceptability and adverse effect profile in a general practice setting.
    Riney S; O'Shea B; Forde A
    Ir Med J; 2009 Jan; 102(1):24-5. PubMed ID: 19284015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users.
    Wong RC; Bell RJ; Thunuguntla K; McNamee K; Vollenhoven B
    Contraception; 2009 Nov; 80(5):452-6. PubMed ID: 19835719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.
    Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E;
    Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system.
    Weisberg E; Bateson D; McGeechan K; Mohapatra L
    Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):5-14. PubMed ID: 24229367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side effects and acceptability of Implanon: a pilot study conducted in eastern Turkey.
    Yildizbas B; Sahin HG; Kolusari A; Zeteroglu S; Kamaci M
    Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):248-52. PubMed ID: 17763263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant.
    Croxatto HB
    Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():21-8. PubMed ID: 11246604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia.
    Harvey C; Seib C; Lucke J
    Contraception; 2009 Dec; 80(6):527-32. PubMed ID: 19913146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital.
    Aisien AO; Enosolease ME
    Niger J Clin Pract; 2010 Sep; 13(3):331-5. PubMed ID: 20857796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implanon. The new alternative.
    Cherry S
    Aust Fam Physician; 2002 Oct; 31(10):897-900. PubMed ID: 12404826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year assessment of women receiving sub-dermal contraceptive implant at Siriraj Family Planning Clinic.
    Thamkhantho M; Jivasak-Apimas S; Angsuwathana S; Chiravacharadej G; Intawong J
    J Med Assoc Thai; 2008 Jun; 91(6):775-80. PubMed ID: 18697372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' perspectives about why they have their contraceptive Implanon NXT device removed early.
    Flore M; Chen XL; Bonney A; Mullan J; Dijkmans-Hadley B; Hodgkins A; Evans G; Frew H; Lloyd G
    Aust Fam Physician; 2016 Oct; 45(10):740-744. PubMed ID: 27695725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
    Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
    Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of Implanon on menstrual bleeding patterns.
    Mansour D; Korver T; Marintcheva-Petrova M; Fraser IS
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():13-28. PubMed ID: 18330814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain.
    Arribas-Mir L; Rueda-Lozano D; Agrela-Cardona M; CedeƱo-Benavides T; Olvera-Porcel C; Bueno-Cavanillas A
    Contraception; 2009 Nov; 80(5):457-62. PubMed ID: 19835720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertion and removal of Implanon: practical considerations.
    Mascarenhas L
    Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():29-34. PubMed ID: 11246605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability and clinical safety of Implanon.
    Blumenthal PD; Gemzell-Danielsson K; Marintcheva-Petrova M
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():29-36. PubMed ID: 18330815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implanon sub-dermal implants: a 10-month review of acceptability in Jos, North-Central Nigeria.
    Mutihir JT; Daru PH
    Niger J Clin Pract; 2008 Dec; 11(4):320-3. PubMed ID: 19320403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "I think it depends on the body, with mine it didn't work": explaining young women's contraceptive implant removal.
    Hoggart L; Newton VL; Dickson J
    Contraception; 2013 Nov; 88(5):636-40. PubMed ID: 23829976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon.
    Weisberg E; Hickey M; Palmer D; O'Connor V; Salamonsen LA; Findlay JK; Fraser IS
    Hum Reprod; 2006 Jan; 21(1):295-302. PubMed ID: 16284061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.